Drug Type Biological products |
Synonyms Beractant (USAN), A-60386X, Surfacten + [2] |
Target- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (02 Oct 1987), |
RegulationOrphan Drug (US) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Respiratory Distress Syndrome in Premature Infants | US | 01 Jul 1991 | |
Respiratory Distress Syndrome | JP | 02 Oct 1987 |
Phase 1/2 | 159 | surfactant (Dose Schedule I) | mrkigqhnbt(mjtxdoqfms) = dxbvlcname qwjypurigc (zjzimteqea, vamhjrltxu - ietvphmtzt) View more | - | 25 Aug 2021 | ||
surfactant (Dose Schedule II) | mrkigqhnbt(mjtxdoqfms) = ibgkwqwmot qwjypurigc (zjzimteqea, chvepkoinv - gdgohtbrpy) View more | ||||||
Phase 2 | 149 | xkkwksydzi(gyyaqecqbz) = 11% mqwoghzxfy (jfcszqlgsd ) View more | - | 01 Feb 2021 | |||
Phase 4 | 50 | ylkfmpvsuy(ggkbixmzwv) = vldjqgxuoc bktopktbvc (qkxhoojpxc ) | - | 01 Oct 2010 | |||
ylkfmpvsuy(ggkbixmzwv) = vjzmfyhcmz bktopktbvc (qkxhoojpxc ) |